Zeo ScientifiX Management
Management criteria checks 4/4
Zeo ScientifiX's CEO is Ian Bothwell, appointed in Nov 2016, has a tenure of 5.17 years. total yearly compensation is $208.32K, comprised of 80% salary and 20% bonuses, including company stock and options. directly owns 11.24% of the company’s shares, worth $2.58M. The average tenure of the management team and the board of directors is 2.2 years and 3.7 years respectively.
Key information
Ian Bothwell
Chief executive officer
US$208.3k
Total compensation
| CEO salary percentage | 80.0% |
| CEO tenure | 8yrs |
| CEO ownership | 11.2% |
| Management average tenure | 2.2yrs |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jul 31 2024 | n/a | n/a | -US$5m |
| Apr 30 2024 | n/a | n/a | -US$5m |
| Jan 31 2024 | n/a | n/a | -US$6m |
| Oct 31 2023 | US$208k | US$167k | -US$7m |
| Jul 31 2023 | n/a | n/a | -US$9m |
| Apr 30 2023 | n/a | n/a | -US$10m |
| Jan 31 2023 | n/a | n/a | -US$10m |
| Oct 31 2022 | US$536k | US$300k | -US$9m |
| Jul 31 2022 | n/a | n/a | -US$7m |
| Apr 30 2022 | n/a | n/a | -US$6m |
| Jan 31 2022 | n/a | n/a | -US$6m |
| Oct 31 2021 | US$3m | US$300k | -US$13m |
| Jul 31 2021 | n/a | n/a | -US$17m |
| Apr 30 2021 | n/a | n/a | -US$21m |
| Jan 31 2021 | n/a | n/a | -US$20m |
| Oct 31 2020 | US$2m | US$300k | -US$13m |
| Jul 31 2020 | n/a | n/a | -US$8m |
| Apr 30 2020 | n/a | n/a | -US$3m |
| Jan 31 2020 | n/a | n/a | -US$2m |
| Oct 31 2019 | US$277k | US$277k | -US$2m |
| Jul 31 2019 | n/a | n/a | -US$1m |
| Apr 30 2019 | n/a | n/a | -US$1m |
| Jan 31 2019 | n/a | n/a | -US$4m |
| Oct 31 2018 | US$843k | US$252k | -US$3m |
Compensation vs Market: Ian's total compensation ($USD208.32K) is below average for companies of similar size in the US market ($USD647.72K).
Compensation vs Earnings: Ian's compensation has been consistent with company performance over the past year.
CEO
Ian Bothwell (64 yo)
8yrs
Tenure
US$208,315
Compensation
Mr. Ian T. Bothwell has been the Chief Financial Officer of Zeo ScientifiX, Inc. (formerly known as Organicell Regenerative Medicine, Inc.) since November 4, 2016 and serves as its Director since September...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO | 8yrs | US$208.32k | 11.24% $ 2.6m | |
| Chief Medical Officer & Director | 6.2yrs | US$100.00k | 6.12% $ 1.4m | |
| Vice President of Operation | 1.8yrs | no data | no data | |
| Chief Information Officer | 2.2yrs | no data | no data | |
| Chief Product Officer | 1.8yrs | no data | no data |
2.2yrs
Average Tenure
Experienced Management: ZEOX's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO | 5.2yrs | US$208.32k | 11.24% $ 2.6m | |
| Chief Medical Officer & Director | 5.8yrs | US$100.00k | 6.12% $ 1.4m | |
| Independent Director | 2.2yrs | no data | 0% $ 0 | |
| Independent Chairman of the Board | 2.2yrs | no data | 0% $ 0 | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data |
3.7yrs
Average Tenure
63.5yo
Average Age
Experienced Board: ZEOX's board of directors are considered experienced (3.7 years average tenure).